German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks ...

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

Boston Children’s Hospital is pausing its plans to move into the five floors of a Fenway lab building that it purchased two ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ...

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Q1 2025 Management View CEO Mike Mahoney highlighted strong Q1 performance, with operational sales growth of 22% and organic ...

Boston Scientific raised its annual profit forecast and said strong demand for its medical devices would buffer a potential $200 million tariff-related hit, sending its shares up nearly 6% on ...

Boston Scientific also announced that it has appointed Jon Monson, currently senior vice president of investor relations, to the role of chief financial officer, effective June 30. He succeeds Dan ...